Using a modified poliovirus to enhance cancer immunotherapy
Resolving Spatiotemporal Dynamics of Recombinant Poliovirus Immunotherapy
This study is looking at how a special version of the poliovirus can help boost your immune system to better fight cancer by targeting important immune cells, and it could offer a new way to improve cancer treatment for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10895543 on NIH RePORTER |
What this research studies
This research investigates how a modified poliovirus can be used to improve the immune system's ability to fight cancer. It focuses on a specific type of immune cell, called dendritic cells, which are crucial for presenting tumor antigens to other immune cells. By using a safe version of the poliovirus that targets these dendritic cells, the study aims to stimulate a stronger immune response against tumors. Patients may benefit from this innovative approach to immunotherapy that seeks to overcome challenges in cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancers that may benefit from enhanced immune responses, particularly those involving dendritic cell interactions.
Not a fit: Patients with non-cancerous conditions or those whose tumors do not involve the immune mechanisms targeted by this research may not benefit.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer immunotherapies that harness the body's immune system to target and destroy tumors.
How similar studies have performed: Previous research has shown promise in using viral vectors for immunotherapy, indicating that this approach may be viable and effective.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Gromeier, Matthias — Duke University
- Study coordinator: Gromeier, Matthias
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.